This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Magnus, C.
Right arrow Articles by Regoes, R. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Magnus, C.
Right arrow Articles by Regoes, R. R.

 Previous Article  |  Next Article 

Journal of Virology, February 2009, p. 1523-1531, Vol. 83, No. 3
0022-538X/09/$08.00+0     doi:10.1128/JVI.01764-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Estimating the Stoichiometry of Human Immunodeficiency Virus Entry{triangledown}

Carsten Magnus,1 Peter Rusert,2 Sebastian Bonhoeffer,1 Alexandra Trkola,2 and Roland R. Regoes1*

Integrative Biology, ETH Zurich, Zurich, Switzerland,1 Division of Infectious Diseases, University Hospital Zurich, Zurich, Switzerland2

Received 21 August 2008/ Accepted 7 November 2008

To enter target cells, human immunodeficiency virus (HIV) first attaches to the cells and fuses with the cell membrane. Attachment and fusion involve envelope glycoprotein trimers on the surface of the virion and the CD4 receptor and chemokine coreceptors on the surface of the target cell. The stoichiometry of entry, that is, the number of bonds between such trimers and CD4 that are required for infection, is unknown. Pseudotyped virions that express mixed trimers consisting of functional and nonfunctional envelope proteins have been used to study how many trimer-receptor interactions are required for virus entry. However, to extract information on the stoichiometry of entry from data generated in in vitro infectivity assays with such viruses, mathematical models are required. Here, we describe mathematical models that can be used to infer the stoichiometry of entry. By fitting our simplest model to previously published data (X. Yang, S. Kurteva, X. Ren, S. Lee, and J. Sodroski, J. Virol. 79: 12132-12147, 2005), we estimated that the number of trimer-receptor interactions required for HIV to infect a target cell is approximately eight, which is higher than previous estimates. We also consider model extensions that explain some systematic deviations of the data from the prediction of the simplest model. However, these extended models yield very different estimates of the stoichiometry of entry ranging from 2 to 19. These results strongly suggest that, based on our present knowledge of HIV entry, the stoichiometry of this process cannot be reliably estimated. Our study identifies parameters that need to be defined to render the estimation of the stoichiometry of HIV entry possible.


* Corresponding author. Mailing address: Institute of Integrative Biology, ETH Zurich, ETH Zentrum, CHN H76.2, Universitaetsstr. 16, CH-8092 Zurich, Switzerland. Phone: 41-44-632-6935. Fax: 41-44-632-1271. E-mail: roland.regoes{at}env.ethz.ch

{triangledown} Published ahead of print on 19 November 2008.


Journal of Virology, February 2009, p. 1523-1531, Vol. 83, No. 3
0022-538X/09/$08.00+0     doi:10.1128/JVI.01764-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Le Duff, Y., Blanchet, M., Sureau, C. (2009). The Pre-S1 and Antigenic Loop Infectivity Determinants of the Hepatitis B Virus Envelope Proteins Are Functionally Independent. J. Virol. 83: 12443-12451 [Abstract] [Full Text]  
  • Agrawal-Gamse, C., Lee, F.-H., Haggarty, B., Jordan, A. P. O., Yi, Y., Lee, B., Collman, R. G., Hoxie, J. A., Doms, R. W., Laakso, M. M. (2009). Adaptive Mutations in a Human Immunodeficiency Virus Type 1 Envelope Protein with a Truncated V3 Loop Restore Function by Improving Interactions with CD4. J. Virol. 83: 11005-11015 [Abstract] [Full Text]